Infectious Diseases (all articles)
M-A | Prevalence of occult hepatitis B virus infection in adults.
15 Aug, 2022 | 11:59h | UTC
Commentary on Twitter
New Article online — a systematic review and meta-analysis of the prevalence of occult #HBV infection in adults — FREE to read https://t.co/oaa1HHfQo0@dryuriim @leithdamien @chipsliverlover @GeYueqi @gndow @maud_lemoine #LiverTwitter #IDtwitter #viralhepatitis #hepatitisB pic.twitter.com/liMf9CBAzK
— The Lancet Gastroenterology & Hepatology (@LancetGastroHep) August 10, 2022
RCT | Safety and immunogenicity of a typhoid conjugate vaccine among children aged 9 months to 12 years in Malawi.
15 Aug, 2022 | 11:55h | UTCCommentaries:
New TCV data from Malawi highlight longer-term immune response – Coalition Against Typhoid
Related:
Randomized Trial: Efficacy Analysis of a Typhoid Conjugate Vaccine
M-A | Interventions to reduce infections in patients with hematological malignancies.
15 Aug, 2022 | 11:51h | UTCCommentary: Prophylactic Immunoglobulin, Vaccinations May Reduce Infections in Hematologic Malignancies – AJMC
Review | The COVID-19 pandemic and its consequences for chronic pain.
12 Aug, 2022 | 15:02h | UTCThe COVID-19 pandemic and its consequences for chronic pain: a narrative review – Anaesthesia
Commentary on Twitter
🔐Time to pay attention to the consequences of persistent pain in patients after any severity of COVID-19, with increased risk of post-intensive care syndrome in patients requiring ICU care?@harshamd5 @ANels_MD @NarouzeMD #FreeForAWeek
🔗https://t.co/NaafjxCbXz pic.twitter.com/Zj2OGIPniP
— 𝘈𝘯𝘢𝘦𝘴𝘵𝘩𝘦𝘴𝘪𝘢 (@Anaes_Journal) August 1, 2022
Review | Cardiovascular complications of pregnancy-associated COVID-19 infections.
12 Aug, 2022 | 15:14h | UTCCommentaries:
Cardiovascular Complications of COVID-19 in Pregnancy Reviewed – HealthDay
Age–sex differences in the global burden of lower respiratory infections and risk factors, 1990–2019: results from the Global Burden of Disease Study 2019.
12 Aug, 2022 | 14:58h | UTCInvited Commentary: Trends in the global burden of lower respiratory infections: the knowns and the unknowns – The Lancet Infectious Diseases
Commentary on Twitter (thread – click for more)
New Research: Age–sex differences in the global burden of lower respiratory infections and risk factors, 1990–2019: results from the Global Burden of Disease Study 2019 https://t.co/rhV7lRaZvc (1/2) pic.twitter.com/I0INjaMh4I
— The Lancet Infectious Diseases (@TheLancetInfDis) August 12, 2022
M-A | Diagnostic accuracy of urinary antigen tests for pneumococcal pneumonia among patients with acute respiratory failure suspected pneumonia.
12 Aug, 2022 | 14:28h | UTC
Podcast | Meningitis pearls.
12 Aug, 2022 | 14:25h | UTC#346 Meningitis – The Curbsiders
RCT | Tobramycin inhalation solution is effective in adults with bronchiectasis with pseudomonas aeruginosa infection.
11 Aug, 2022 | 12:15h | UTCCommentary: Tobramycin Tames Infection in Bronchiectasis – Medscape (free registration required)
Retrospective cohort study | In patients with recurrent prosthetic joint infection after attempted surgical eradication, chronic antibiotic suppression may be a reasonable strategy in patients who lack or refuse further surgical treatment options.
10 Aug, 2022 | 12:17h | UTCPredictors of Success with Chronic Antibiotic Suppression for Prosthetic Joint Infections – The Journal of Arthroplasty (link to abstract – $ for full-text)
Commentary: Chronic antibiotic suppression may successfully treat periprosthetic joint infections – Healio (free registration required)
Guideline Synopsis | Treatment of Clostridioides difficile infection.
9 Aug, 2022 | 12:54h | UTCTreatment of Clostridioides difficile Infection – JAMA (free for a limited period)
Original Guideline: ACG Clinical Guidelines: Prevention, Diagnosis, and Treatment of Clostridioides difficile Infections – American Journal of Gastroenterology
Related Guidelines:
Commentary on Twitter
A summary of @AmCollegeGastro’s 2021 guidelines on treatment of Clostridioides difficile infection. https://t.co/QzrMa71ttu
— JAMA (@JAMA_current) August 8, 2022
M-A | Immunogenicity, safety, and efficacy of the HPV vaccines among people living with HIV.
9 Aug, 2022 | 12:41h | UTC
Inhaled antibiotics in critical care: state of the art and future perspectives.
9 Aug, 2022 | 12:30h | UTC
Review | Role of imaging in CNS infections.
9 Aug, 2022 | 12:26h | UTCRole of imaging in CNS infections – Indian Journal of Pathology & Microbiology
Antimicrobial dosing recommendations in pediatric continuous renal replacement therapy: a critical appraisal of current evidence.
5 Aug, 2022 | 13:58h | UTC
Phase 1 Study | Low-dose subcutaneous or intravenous monoclonal antibody can prevent malaria in a human challenge model.
4 Aug, 2022 | 14:45h | UTCEditorial: Monoclonal Antibodies for Malaria – New England Journal of Medicine
Case-Control Study | Outpatient oral macrolide use is associated with increased risk of sensorineural hearing loss in children, adolescents, and young adults.
4 Aug, 2022 | 14:29h | UTCAssociation of Outpatient Oral Macrolide Use With Sensorineural Hearing Loss in Children, Adolescents, and Young Adults – JAMA Otolaryngology-Head & Neck Surgery (link to abstract – $ for full-text)
Commentary: Kids’ Hearing Loss Associated With Common Antibiotics — Children and teens with sensorineural hearing loss more often macrolide users – MedPage Today (free registration required)
RCT | 72 weeks post-partum follow-up of dolutegravir versus efavirenz initiated in late pregnancy.
4 Aug, 2022 | 14:33h | UTCRelated:
WHO Recommends Dolutegravir as Preferred HIV Treatment Option in All Populations
RCT: Dolutegravir or Darunavir in combination with Zidovudine or Tenofovir to treat HIV.
M-A | Efficacy of Doxycycline for mild-to-moderate community-acquired pneumonia in adults.
4 Aug, 2022 | 14:17h | UTCEfficacy of Doxycycline for Mild-to-moderate Community-acquired Pneumonia in Adults: A Systematic Review and Meta-analysis of Randomized Controlled Trials – Clinical Infectious Diseases (link to abstract – $ for full-text)
Commentary on Twitter
🆕⚡⚡Systematic Review and Meta-analysis of Randomized Controlled Trials @CIDJournal
Efficacy of Doxycycline for Mild-to-moderate CAP in Adults
The efficacy of doxycycline was comparable to macrolides or fluoroquinolones in mild-moderate CAP #IDTwitter https://t.co/L7UBBUc4Dm— Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 (@ABsteward) July 29, 2022
M-A | The global burden of sore throat and group A Streptococcus pharyngitis.
4 Aug, 2022 | 13:33h | UTC
Network M-A | Evidence synthesis evaluating body weight gain among people treating HIV with antiretroviral therapy.
4 Aug, 2022 | 13:30h | UTC
Commentary on Twitter
A new systematic review aimed to evaluate how different #ART regimens compare with respect to body #weight gains over time and associated risk factors.
Read here: https://t.co/MHC1Ysgb34 pic.twitter.com/0djjGPmlcW
— eClinicalMedicine – The Lancet Discovery Science (@eClinicalMed) May 24, 2022
RECOVERY Trial | Baricitinib in patients admitted to hospital with COVID-19.
3 Aug, 2022 | 14:34h | UTCInvited Commentary: Baricitinib in COVID-19: a coming-of-age from artificial intelligence to reducing mortality – The Lancet
Related:
WHO recommends two new drugs to treat COVID-19 – World Health Organization
Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19 – New England Journal of Medicine
Commentary on Twitter
New @TheLancet
The largest trial of baricitinib, a JAK-inhibitor drug repurposed via #AI data mining, reduced Covid mortality and the overall reduction consistent with 8 previous RCTs (~20%)https://t.co/5fHDBBvm3Q pic.twitter.com/GDFzcU26H6— Eric Topol (@EricTopol) July 29, 2022
Under a Creative Commons Attribution (CC BY 4.0) license
Antivirals with activity against Monkeypox: a clinically oriented review.
3 Aug, 2022 | 14:26h | UTCRelated:
WHO chief advises men who have sex with men to reduce partners to limit exposure to monkeypox – CNN
WHO Declares Global Public Health Emergency Over Monkeypox Virus Outbreak – Health Policy Watch
Monkeypox: A Contemporary Review for Healthcare Professionals – Open Forum Infectious Diseases
Review | Diagnosis, treatment, and prevention of Malaria in the US.
3 Aug, 2022 | 14:27h | UTCDiagnosis, Treatment, and Prevention of Malaria in the US: A Review – JAMA (free for a limited period)
Audio Clinical Review: Diagnosis, Treatment, and Prevention of Malaria in the US – JAMA
Cohort Study | Association of higher-dose fluoroquinolone therapy with serious adverse events in older adults with advanced chronic kidney disease.
3 Aug, 2022 | 14:22h | UTC